VIGABATRIN

Generic: VIGABATRIN

Hikma Pharmaceuticals USA IncManufacturer
ORALRoute
VIGABATRINActive Substance
2022-08-29Original Approval

VIGABATRIN is FDA application ANDA213104, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
SEIZURE
883 reports
2
DRUG INEFFECTIVE
685 reports
3
OFF LABEL USE
355 reports
4
HOSPITALISATION
312 reports
5
ADVERSE EVENT
247 reports
6
DEATH
245 reports
7
EPILEPSY
192 reports
8
MAGNETIC RESONANCE IMAGING HEAD ABNORMAL
187 reports
9
MULTIPLE-DRUG RESISTANCE
177 reports
10
DRUG RESISTANCE
163 reports